Enabling COVID-19 Research
As the SARS-CoV-2 pandemic continues, Beckman Coulter Life Sciences has a firm commitment to enabling our customers to gain a better understanding of this disease and advance much-needed discoveries. For this reason, we compiled relevant resources and tools to support and facilitate your COVID-19 research.
See the latest news regarding our collaborations in our News & Releases section.
Understanding the Immune ResponseCharacterization of the immune response provides critical knowledge of cell phenotype and function that will enable development of therapies with the goal of modulating the immune response.
Viral Isolation & Characterization
Workflow solutions for viral particle characterization including:
- Viral particle isolation
- Characterization at a genetic or whole particle level
- Defining interaction partners
- And more
Vaccine & Therapy Development
Workflow solutions for each step of the process of vaccine and therapy development:
- Isolation and purification of biological molecules
- Cell line development of cell lines
- Screening of drugs
- Efficacy/dosing studies
Wastewater ResearchWe provide a suite of technological solutions that can improve methods for detecting SARS-CoV-2 in wastewater systems. From concentrating samples with our centrifuges to extracting viral RNA with our reagents, our products empower researchers to detect viral RNA at both the cellular and molecular levels.
Beckman Coulter Life Sciences is here for you in challenging times. Find:
- Instrument decontamination instructions
- Remote support through BeckmanConnect
- On-Demand customer training
- COVID-19 resources
- And more
Biosafety Cabinet and Cleanroom Air Safety Monitoring
Routine environmental air particle monitoring plans designed to monitor the air quality of biosafety cabinets and cleanrooms, both to protect the cleanroom staff and the product as well, are tailored to individual cleanrooms and processes and are created through a risk assessment carried out by the cleanroom owner. There are a few guidelines in GMP Annex 1 and CGMP for us to follow for routine environmental particulate monitoring. Learn more.
Read the latest news releases about our collaborations with the U.S. Department of Health and Human Services, genedrive, and Fry Laboratories.
Read more at News & Releases
Danaher is in the fight against COVID-19
Learn the latest developments from Danaher's family of companies including Cepheid, Integrated DNA Technologies, Beckman Coulter and more.Learn more at danaher.com